. data that are of high quality in terms of both accuracy (Brewster et al. 1994) and completeness (Brewster et al. 1997 
ated with significantly better survi' al in the West of Scotland (Gillis and Hole. 1996) . Socioeconomic deprivation has also been associated with worse survival. although tumour stage and pathology did not differ between deprived and affluent women (Carnon et al. 1994) . Finally. in south-east England. survival appeared to be better for women treated in districts with a teaching hospital (Basnett et al. 1992 ) .
This study addresses variability in the survival of women in Scotland identified from cancer registry data who underw ent surgery for breast cancer in 1987. Whereas previous studies have covered several years. over which practice may have changed (Carnon et al. 1994: Gillis and Hole. 1996) . we focused on a single year. Importantly. we obtained detailed clinical information from individual patients' case records rather than registry data alone (Karjalainen and Pukkala. 1990 : Sainsbury et al. 1995a and b: Schrijvers et al. 1995 . Our data are population based rather than derived from a single institution.
PATIENTS AND METHODS

Study population
The study was part of a comprehensive survey of patterns of care in all women with invasive breast cancer recorded by the Scottish Cancer Registry in 1987 and 1993 (Scottish Breast Cancer Focus Group. 1996) . data that are of high quality in terms of both accuracy (Brewster et al. 1994) and completeness (Brewster et al. 1997) . This The clinical factors examined were pathological tumour size (< 2 cm. > 2 cm). pathological node status (positive. negative). oestrogen receptor (ER) status (positive > 20 fmol mg-' cytosolic protein or > 10% staining). patient's age (< 50. 50-64. 65-79 (Armitage and Berry. 1994) . Two models were derived. Both represented survival adjusted first for significant clinical factors: the first model also adjusted for significant service factors. whereas the second model also adjusted for significant treatment factors. We investigated the validity of the Cox models using log (minus log) plots and also time-dependent modelling (Collett. 1994) and found the assumption of proportional hazards to be acceptable.
In proportion of these women were elderly (P < 0.001). When the analysis of all non-metastatic patients was restricted to those less than 75 years old, health board again had a significant effect on survival (P = 0.02).
There appears, therefore, to be an effect of health board on survival that is not fully explained by selection for surgery and is strongest in women aged less than 75 years. One possible explanation is differences between health boards in the use of adjuvant treatment. Table 3 shows variation in the use of adjuvant treatment between health boards. A multivariate logistic regression analysis, adjusted for all of the clinical factors except clinical stage, showed that health board of first treatment predicted independently whether or not patients received adjuvant systemic treatment (P < 0.001).
Effect of deprivation and cae load In the univariate analysis women from less deprived areas appeared to have a better prognosis. but this was not confirmed by the multivariate Cox model (P = 0.03 and 0.28 respectively). This is not due to bias of selection for surgery, as deprivation still had no effect on survival when non-surgical and non-metastatic patients were also included (P = 0.23). For those women who underwent surgery, there were, however, significant differences in ER status between deprivation categories (P-value for X2 of association < 0.001). Women in the most deprived group were more likely to have ER-negative tunours than those in the intermediate or least deprived groups (36%, 22% and 22%, respectively, were ER negative). This variability in ER status accounted, at least in part, for the effect of deprivation in the univariate analysis of surgical cases.
In the univariate analysis, women operated on by surgeons with a large case load appeared to have better 5-year survival (P = 0.03). However, age, clinical stage, node status and ER status all differed between surgeons with differing case loads (all P-values for X of association < 0.001). In the multivariate survival analysis.
the effect of case load was no longer apparent (P = 0.74). suggesting that case mix accounts for the effect on survival in the univariate analysis. Referral to an oncologist did not significantly affect survival.
DISCUSSION
This study shows significant variability in the survival of women with breast cancer that is not fully accounted for by clinical factors. The most important finding is that. although geographical differences in the selection of patients for surgery account for some of this variability, the health board of first treatment has an effect on survival. This may be explained in part by differences in the proportion of patients receiving adjuvant systemic therapy. By contrast, neither surgical case load nor socioeconomic deprivation significantly affected survival when other factors were taken into account. These findings are strengthened by this being a national. population-based study that included 89% of eligible patients diagnosed recently in a single year. across a heterogeneous but well-defined geographical area Importantly, the current study obtained detailed information directly from the case notes rather than relying solely on cancer registry data. The influence of Health Board on survival was less strong than that of clinical factors, but among surgical patients adjusted 5-year survival varied from 67% to 84% between health boards. Variations in survival have also been described between different regions of Yorkshire (Sainsbury et al, 1995b) and between teaching and non-teaching hospitals in the South of England (Basnett et al, 1992) . Part of the variability in survival in the current study was due to the selection of patients for surgery. When all non-metastatic patients, as opposed to only those treated surgically, were included the effect of health board no longer reached statistical significance. However. the patients treated nonsurgically were mostly elderly and at greater risk of death from other causes. When the analysis was restricted to all nonmetastatic patients under 75 years, in whom non-cancer deaths are less common, the effect of health board on survival was again significant. Health board had a similar effect on survival in women undergoing surgery when only breast cancer deaths were considered (P = 0.05; data not shown). There appears. therefore, to be an effect of health board on survival that is greatest in women less than 75 years old.
This remaining variation in survival may be due to differences in the use of adjuvant systemic therapy, in most cases tamoxifen. between the health boards. There was a trend for survival to be worse in those health boards in which adjuvant systemic treatmient was less widely used ( Figure 1 ). This is a plausible explanation given the known effect of adjuvant treatment on survival in clinical trials (Early Breast Cancer Trialists' Collaborative Group. 1992 ). In our analysis, the effect of adjuvant systemic treatment did not achieve statistical significance, possibly because it was not a randomized trial, hence the use of treatment was confounded or driven by clinical factors. In the current analysis, the adjusted 5-year survival for women given any adjuvant systemic treatment was 75% (99% CI 72-78%), compared with 72% (99% CI 69-75%) in those who did not receive such treatment. This difference was not statistically significant. but is of the same magnitude as the known 3.5% survival advantage of adjuvant systemic treatment at 5 years (Early Breast Cancer Trialists' Collaborative Group, 1992) . Our study, however, had only 35% power (Parmnar and Machin. 1995) to detect a survival advantage of the magnitude reported in the overviewv. The importance of a relationship between rates of use of adjuvant treatment and survival is supported by the geographical variations in the treatment of breast cancer in other parts of Britain (Basnett et al. 1992 : Chouillet et al. 1994 : Sainsburv et al. 1995b : Richards et al. 1996 . In Scotland. there was a substantial and appropriate increase in the use of adjuvant systemic treatment between 1987 (Scottish Breast Cancer Focus Group et al. 1996 . the impact of which will be apparent when survival data from the 1993 cohort of women are mature.
Previous studies have sucyested that survival is better for patients of surgeons seeing at least 30 women with breast cancer each year (Sainsburv et al. 1995a) or with a perceived interest in breast cancer. irrespective of their case load (Gillis and Hole. 1996) . Our data support those of Sainsbury et al (1995a) in that surgical caseload significantly influenced unadjusted survival.
However. this effect appeared to be explained by case mix as it was no longer apparent after adjusting for other prognostic factors that were better characterized by the more detailed data collection in the current studv. We did not categorize surgeons in the same way as Gillis and Hole (1996) . who defined 'specialist' breast cancer surgeons after taking advice according to informed opinion and not numerically by case load. Nevertheless. taken together. these studies suaaest that there is a 'surgeon effect' but this relates to better overall care rather than the numbers of women operated upon. Indeed. the Yorkshire study showed that surgeons with a higher case load were also more likely to use chemotherapy and hormone therapy (Sainsbur et al. 1995b ).
Our findings in relation to deprivation and unadjusted survival support data adjusted only for age in 7537 women from the West of Scotland Cancer Registrv (Carnon et al. 1994 ). When we adjusted survival for other factors. in particular ER status. the trend for poorer survival in the more deprived women persisted. but was no longer statistically significant. Unlike the current studv. Carnon et al ( 1994) did not adjust survival for known prognostic factors. Rather. they looked at a subgroup of 1361 women and found no differences in pathological features between the deprived and affluent women. Carnon et al (1994) did not. however. report any relationship between adjusted survival and depri'vation in this subgroup of women for whom they had pathology data. Many other earlier studies used only registr data and were also able to adjust for a limited number of prognostic factors (Marshall & Funch. 1983 : Karjalainen and Pukkala. 1990 : Schrijvers et al. 1995 . The current large. detailed population study verifies that deprivation influences unadjusted survival but appears not to be a significant. independent prognostic factor for survival. The effect of deprivation on the survival of women with breast cancer remains unproved.
The increasing evidence that service factors related to the deliverv of health care affect survival has important implications for the provision of cancer services. The current study suggests that regional differences in practice. probably related to the use of adjuvant systemic treatment. man influence survival in women with early breast cancer. It is clear that too many hospitals are treating women with breast cancer and that many do not have the multidisciplinary teams needed for optimal care (Richards et al. 1996) . Currently. only half the patients with cancer in Britain are seen by an oncologist (Richards and Parrott. 1996) and the majority of women are not operated on by a surgeon with a special interest in breast cancer (Gillis and Hole. 1996) . It is important that the development of specialist breast cancer services continues British Journal of Cancer (1998) 
